Shionogi & Co Ltd - Strategy, SWOT and Corporate Finance Report

Shionogi & Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Shionogi & Co Ltd (Shionogi) focuses on the research, development, manufacturing and marketing of pharmaceutical products, diagnostic reagents and medical devices. The company's core pharmaceuticals product business offers drugs for the treatment of disorders in the areas of metabolism, infection, immunity and cancer pain. Shionogi also sells, distributes and provides information about diagnostic products in the fields of infectious diseases, cardiovascular diseases and allergies. The company operates a network of subsidiaries, branches, sales offices manufacturing plants and research laboratories across Japan, China, Taiwan in Asia; North America and Europe. Shionogi is headquartered in Osaka, Japan.

Scope

  • Detailed information on Shionogi & Co Ltd required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Shionogi & Co Ltd in the form of a SWOT analysis
  • An in-depth view of the business model of Shionogi & Co Ltd including a breakdown and examination of key business segments
  • News about Shionogi & Co Ltd, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Shionogi & Co Ltd and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Shionogi & Co Ltd as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Shionogi & Co Ltds business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Takeda Pharmaceutical Co Ltd

Santen Pharmaceutical Co Ltd

Otsuka Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

Chugai Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd

Santen Pharmaceutical Co Ltd

Otsuka Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

Chugai Pharmaceutical Co Ltd

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Shionogi & Co Ltd - Key Facts ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Shionogi & Co Ltd - Key Facts

Shionogi & Co Ltd - Key Employees

Shionogi & Co Ltd - Key Employee Biographies

Shionogi & Co Ltd - Major Products and Services

Shionogi & Co Ltd - History

Shionogi & Co Ltd - Company Statement

Shionogi & Co Ltd - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Company Overview

Shionogi & Co Ltd - Business Description

Shionogi & Co Ltd - Corporate Strategy

Shionogi & Co Ltd - SWOT Analysis

SWOT Analysis - Overview

Shionogi & Co Ltd - Strengths

Shionogi & Co Ltd - Weaknesses

Shionogi & Co Ltd - Opportunities

Shionogi & Co Ltd - Threats

Shionogi & Co Ltd - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Shionogi & Co Ltd, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 24, 2019: Shionogi agrees to license-out lusutrombopag

May 13, 2019: Shionogi releases AMR Position Paper

Apr 01, 2019: Shionogi announces the commencement of its operations of Shionogi Pharma

Mar 10, 2019: Shionogi likely to shift its HQ to Netherlands

Feb 28, 2019: Shionogi enters into comprehensive cooperation agreement in the field of infectious diesease focused on malaria with Nagasaki University

Feb 19, 2019: SHIONOGI to announce corporate reorganization and personnel reassignment

Oct 29, 2018: Notice Regarding Reorganization of Manufacturing Subsidiaries through Company Split and Merger

Oct 18, 2018: Shionogi to announce corporate personnel reassignment

Oct 17, 2018: Shionogi established new manufacturing subsidiary in Japan

Oct 12, 2018: Shionogi Received “2018 Award for Excellence in Corporate Disclosure” from the Securities Analysts Association of Japan (SAAJ)

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Shionogi & Co Ltd, Key Facts

Shionogi & Co Ltd, Key Employees

Shionogi & Co Ltd, Key Employee Biographies

Shionogi & Co ...

List of Tables

Shionogi & Co Ltd, Key Facts

Shionogi & Co Ltd, Key Employees

Shionogi & Co Ltd, Key Employee Biographies

Shionogi & Co Ltd, Major Products and Services

Shionogi & Co Ltd, History

Shionogi & Co Ltd, Other Locations

Shionogi & Co Ltd, Subsidiaries

Shionogi & Co Ltd, Joint Venture

Shionogi & Co Ltd, Key Competitors

Shionogi & Co Ltd, Ratios based on current share price

Shionogi & Co Ltd, Annual Ratios

Shionogi & Co Ltd, Annual Ratios (Cont...1)

Shionogi & Co Ltd, Annual Ratios (Cont...2)

Shionogi & Co Ltd, Interim Ratios

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Shionogi & Co Ltd, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Shionogi & Co Ltd, Performance Chart (2015 - 2019)

Shionogi & Co Ltd, Ratio Charts

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, ...

List of Figures

Shionogi & Co Ltd, Performance Chart (2015 - 2019)

Shionogi & Co Ltd, Ratio Charts

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports